Literature DB >> 10942602

Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells.

L A Tintignac1, M P Leibovitch, M Kitzmann, A Fernandez, B Ducommun, L Meijer, S A Leibovitch.   

Abstract

Proliferating myoblasts already express MyoD before the induction of differentiation. Overexpression of MyoD in normal and transformed cell lines was shown to block cells from entering S phase, suggesting that the MyoD growth suppressive effect must be tightly controlled in growing myoblasts. Here we show that during G1 phase, but not in G2, MyoD abundance is down-regulated by the ubiquitin-proteasome pathway through phosphorylation of serine 200. Roscovitine, a specific inhibitor of cyclin-Cdk2 complexes, prevents both phosphorylation and degradation of MyoD in G1. Inhibition of the ubiquitin-dependent proteasome pathway by MG132 results in stabilization of MyoD-wt, with little effect on a MyoD mutant where serine 200 is replaced by an alanine. Our results show that MyoD Ser200 is the substrate for phosphorylation by cyclin E-Cdk2 stimulating its degradation by the ubiquitin-proteasome system which controls MyoD levels in G1. Phosphorylation/degradation of MyoD at the end of G1 thus represents the regulatory checkpoint in growing myoblasts allowing progression into S phase in a manner similar to the recently examplified cdk2-phosphorylation/degradation of p27(Kip1). Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942602     DOI: 10.1006/excr.2000.4973

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  20 in total

1.  p27Kip1 acts downstream of N-cadherin-mediated cell adhesion to promote myogenesis beyond cell cycle regulation.

Authors:  Graziella Messina; Cristiana Blasi; Severina Anna La Rocca; Monica Pompili; Attilio Calconi; Milena Grossi
Journal:  Mol Biol Cell       Date:  2005-01-12       Impact factor: 4.138

2.  The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts.

Authors:  Mario Galindo; Jitesh Pratap; Daniel W Young; Hayk Hovhannisyan; Hee-Jeong Im; Je-Yong Choi; Jane B Lian; Janet L Stein; Gary S Stein; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2005-03-21       Impact factor: 5.157

3.  A population of G2-arrested cells are selected as sensory organ precursors for the interommatidial bristles of the Drosophila eye.

Authors:  Joy H Meserve; Robert J Duronio
Journal:  Dev Biol       Date:  2017-06-21       Impact factor: 3.582

4.  A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program.

Authors:  A Mal; M Sturniolo; R L Schiltz; M K Ghosh; M L Harter
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

5.  Down-regulation of MyoD by calpain 3 promotes generation of reserve cells in C2C12 myoblasts.

Authors:  Pascal Stuelsatz; Frédéric Pouzoulet; Yann Lamarre; Elise Dargelos; Sylvie Poussard; Serge Leibovitch; Patrick Cottin; Philippe Veschambre
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

6.  Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.

Authors:  Lionel A J Tintignac; Valentina Sirri; Marie Pierre Leibovitch; Yann Lécluse; Maria Castedo; Didier Metivier; Guido Kroemer; Serge A Leibovitch
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

7.  A distinct profile of myogenic regulatory factor detection within Pax7+ cells at S phase supports a unique role of Myf5 during posthatch chicken myogenesis.

Authors:  Kenneth Day; Bruce Paterson; Zipora Yablonka-Reuveni
Journal:  Dev Dyn       Date:  2009-04       Impact factor: 3.780

8.  Regulation of neurogenin stability by ubiquitin-mediated proteolysis.

Authors:  Jonathan M D Vosper; Christelle S Fiore-Heriche; Ian Horan; Kate Wilson; Helen Wise; Anna Philpott
Journal:  Biochem J       Date:  2007-10-15       Impact factor: 3.857

9.  The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis.

Authors:  James Dr Knight; Rashmi Kothary
Journal:  Skelet Muscle       Date:  2011-09-08       Impact factor: 4.912

10.  Multiple phosphorylation events control mitotic degradation of the muscle transcription factor Myf5.

Authors:  Christine Doucet; Gustavo J Gutierrez; Catherine Lindon; Thierry Lorca; Gwendaline Lledo; Christian Pinset; Olivier Coux
Journal:  BMC Biochem       Date:  2005-12-01       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.